Skip to main content

Table 1 Baseline characteristics of study patients according to the presence of ischemia lesion

From: Relation between quantity and quality of peri-coronary epicardial adipose tissue and its underlying hemodynamically significant coronary stenosis

 

Total (n = 45)

Non-ischemia patient(n = 20)

Ischemia patient (n = 25)

P value

Clinical variable

Age (years)

59.6 ± 4.7

58.2 ± 4.8

60.7 ± 4.4

0.073

Male

34 (75.6)

13 (65.0)

21 (84.0)

0.176

Body weight (kg)

73.8 ± 11.1

74.7 ± 13.5

73.1 ± 9.0

0.649

Height (m)

1.69 ± 0.08

1.69 ± 0.09

1.70 ± 0.07

0.689

BMI (kg/m2)

25.7 ± 2.8

26.1 ± 3.2

25.4 ± 2.4

0.382

BSA (m2)

1.86 ± 0.18

1.86 ± 0.21

1.85 ± 0.14

0.818

Hypertension

26 (57.8)

10 (50.0)

16 (64.0)

0.379

Diabetes mellitus

13 (28.9)

3 (15.0)

10 (40.0)

0.100

Hypercholesteromia

15 (33.3)

6 (30.0)

9 (36.0)

0.757

Current smoking

17 (37.8)

5 (25.0)

12 (48.0)

0.135

PAD or stroke

3 (6.7)

2 (10.0)

1 (4.0)

0.577

Family history of CAD

5 (11.1)

2 (10.0)

3 (12.0)

1.000

LVEF (%)

65.2 ± 5.3

66.4 ± 5.6

64.2 ± 5.0

0.181

Procedural variable

Time interval (day)

11.3 ± 8.4

12.9 ± 9.2

10.1 ± 7.7

0.304

No. of diseased vessels

0.005

 0-vessel disease a

2 (4.4)

2 (10.0)

0

 1-vessel disease

30 (66.7)

17 (85.0)

13 (52.0)

 2-vessel disease

7 (15.6)

1 (5.0)

6 (24.0)

 3-vessel disease

6 (13.3)

0

6 (24.0)

No. of lesions per-patient

1.51 ± 0.73

1.15 ± 0.37

1.80 ± 0.82

0.003

No. of ischemia lesions per-patient

0.67 ± 0.71

0

1.20 ± 0.50

<  0.001

No. of significantly stenotic lesions per-patient

0.47 ± 0.59

0.15 ± 0.37

0.72 ± 0.61

0.001

No. of significantly stenotic patients

19 (42.2)

3 (15.0)

16 (64.0)

0.002

Coronary intervention

13 (28.9)

0

13 (52.0)

<  0.001

No. of stents

0.36 ± 0.61

0

0.64 ± 0.70

<  0.001

Length of stents

9.04 ± 15.66

0

16.3 ± 18.1

<  0.001

EATparameter

Total EAT volume (ml)

89.6 (73.4, 122.8)

84.0 (64.7, 110.5)

102.0 (74.7, 139.8)

0.077

Total EAT volume index (ml/m2)

49.8 (40.5, 64.4)

47.6 (35.1, 55.4)

53.4 (43.1, 71.6)

0.032

Medications on discharge

Aspirin

42 (93.3)

18 (90.0)

24 (96.0)

0.577

Clopidogrel

27 (60.0)

11 (55.0)

16 (64.0)

0.760

Statin

37 (82.2)

15 (75.0)

22 (88.0)

0.435

ACEI/ARB

18 (40.0)

6 (30.0)

12 (48.0)

0.359

Nitrates

28 (62.2)

8 (40.0)

20 (80.0)

0.012

  1. BMI body mass index, BSA body surface area, PAD peripheral artery disease, CAD coronary artery disease, LVEF left ventricular ejection fraction, EAT epicardial adipose tissue, ACEI angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor blocker
  2. aindicated at least one lesion with angiographic diameter stenosis of 30–49% in major epicardial coronary artery